Venture Capital in Biotechnology

Name: Venture Capital in Biotechnology (English version)
SKU: UVAOM1796

Matherne, G. (Paul); Herpfer, Christoph; Dow, Ethan

Product #:UVAOM1796

Supplier:Darden Business School

Discipline:Operations Management

Details:Note (PDF) • 8 pages • 2023-12-05 (Rev: 2024-05-29)

Subjects:

Business management Operations and supply chain management

Industries:

Public administration and nonprofits

Your Price:

$10.54

Purchase this material with a free Educator Account and enjoy more benefits:

Free Educator Copy
Free Teaching Notes
Build your coursepack
Discounted academic price

Pharmaceutical companies have historically relied on their ability to research, develop, manufacture, and sell drug products. Developing a successful drug is a complex and lengthy process, with no guarantee of success, and the total cost of approving a new drug is estimated at $2.5 billion, and rising. This technical note offers an overview of changes in the biotechnology industry related to drug development, focusing on M&A, the milestone model, and venture capital.